Related Experiment Video
Updated: Jul 17, 2026
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
IGFBP3 mRNA expression in benign and malignant breast tumors
Zefang Ren1, Aesun Shin, Qiuyin Cai
1Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt University, S-1121 MCN, 1161 21st Ave, S, Nashville, TN 37232-2587, USA.
Introduction:
Most previous studies have focused on evaluating the association between circulating insulin-like growth factor binding protein 3 (IGFBP-3) levels and breast cancer risk. Emerging evidence over the past few years suggests that IGFBP-3 may act directly on mammary epithelial cells.
Methods:
To understand the role of IGFBP-3 in breast tumorigenesis, we investigated IGFBP3 mRNA expression levels in benign and malignant breast tumors and their adjacent normal tissues using real-time quantitative PCR.
Results:
Cancer tissues had significantly lower IGFBP3 expression than benign tumor tissues (p < 0.001). IGFBP3 expressions in both tumor and adjacent tissues were higher in patients who had proliferative benign tumors than in those who had non-proliferative benign tumors. Among patients with benign breast disease, IGFBP3 expression in the tumor was significantly higher than that in their adjacent normal tissue. There were no apparent associations of IGFBP3 expression in cancer tissues with either overall survival or disease-free survival in a cohort of 521 patients with breast cancer.
Conclusion:
Our findings suggest that the expression level of IGFBP3 in breast tissues may be involved in breast tumorigenesis.
